Xagenic's Series B - II Round

Xagenic raised a round of funding on July 14, 2014. Investors include BDC Healthcare Venture Fund.

Xagenic is a molecular diagnostics company developing a fully automated technology platform that will enable decentralized diagnostic testing to be performed outside of clinical laboratories. Tests ar…

Articles about Xagenic's Series B - II Round: